Product Information
MIRTAZAPINE 45 MG ODT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4081 per EA under NDC 57237001306. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on Dec 8, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
45 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237001306
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077376FDA Approved
12/8/2005
TE Code
AB
On Market Since
2/28/2006
Price Statistics
The NADAC for MIRTAZAPINE 45 MG ODT has been published 652 times since Apr 9, 2014, and over the history we have for it it has declined 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4081 per EA |
|---|---|
| All-time high | $1.2197 (Apr 16, 2014) |
| All-time low | $0.3384 (Nov 20, 2024) |
| 52-week high | $0.5037 |
| 52-week low | $0.3690 |
| Median price | $0.7618 |
| Average price | $0.7259 |
| Largest weekly change | +58.2% (Oct 19, 2022) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 45 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 45 MG ODT, manufactured by Rising Pharma Holdings Inc., is $0.4081 per EA (NDC 57237001306), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 45 MG ODT changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 45 MG ODT has declined 66.5%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 45 MG ODT?
Since Apr 9, 2014, the NADAC for MIRTAZAPINE 45 MG ODT has ranged from a low of $0.3384 (Nov 20, 2024) to a high of $1.2197 (Apr 16, 2014), with a median of $0.7618 per EA.
Are there cheaper alternatives to MIRTAZAPINE 45 MG ODT?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 45 MG TABLET, is $0.1108 per EA — about 73% below MIRTAZAPINE 45 MG ODT.
Who manufactures MIRTAZAPINE 45 MG ODT?
MIRTAZAPINE 45 MG ODT (NDC 57237001306) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.